Carregant…
Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure
Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, as its evidence is lacking in the era of repe...
Autors principals: | , , , , , , , , , , , |
---|---|
Format: | Online Article Text |
Idioma: | English |
Publicat: |
Frontiers Media S.A.
2022
|
Matèries: | |
Accés en línia: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/ https://www.ncbi.nlm.nih.gov/pubmed/35479321 http://dx.doi.org/10.3389/fphar.2022.663811 |